[EN] ARYL-SULFONAMIDE AND ARYL-SULFONE DERIVATIVES AS TRPML MODULATORS<br/>[FR] DÉRIVÉS D'ARYL-SULFONAMIDE ET D'ARYL-SULFONE EN TANT QUE MODULATEURS DE TRPML
申请人:CALYGENE BIOTECHNOLOGY INC
公开号:WO2018208630A1
公开(公告)日:2018-11-15
The new arylsulfonamide and arylsulfone derivatives are modulators of TRPML and are useful in treating disorders related to TRPML activities and lysosome functions such as acid-related disorders and cancer.
新的芳基磺酰胺和芳基砜衍生物是TRPML的调节剂,可用于治疗与TRPML活性和溶酶体功能相关的疾病,如酸相关性疾病和癌症。